These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 12523003)

  • 21. Biochemical findings in common inborn errors of metabolism.
    Pasquali M; Monsen G; Richardson L; Alston M; Longo N
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):64-76. PubMed ID: 16602099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The failure to diagnose inborn errors of metabolism in New Zealand: the case for expanded newborn screening.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Webster D
    N Z Med J; 2007 Sep; 120(1262):U2727. PubMed ID: 17891215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
    J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-methylbutyryl-CoA dehydrogenase deficiency in Hmong infants identified by expanded newborn screen.
    van Calcar SC; Gleason LA; Lindh H; Hoffman G; Rhead W; Vockley G; Wolff JA; Durkin MS
    WMJ; 2007 Feb; 106(1):12-5. PubMed ID: 17393751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
    Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening.
    Koeberl DD; Young SP; Gregersen NS; Vockley J; Smith WE; Benjamin DK; An Y; Weavil SD; Chaing SH; Bali D; McDonald MT; Kishnani PS; Chen YT; Millington DS
    Pediatr Res; 2003 Aug; 54(2):219-23. PubMed ID: 12736383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabonomics of newborn screening dried blood spot samples: a novel approach in the screening and diagnostics of inborn errors of metabolism.
    Dénes J; Szabó E; Robinette SL; Szatmári I; Szőnyi L; Kreuder JG; Rauterberg EW; Takáts Z
    Anal Chem; 2012 Nov; 84(22):10113-20. PubMed ID: 23094949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined use of tandem mass spectrometry with urine gas chromatography/mass spectrometry is useful for diagnosis of inborn errors of metabolism in children].
    Xie LJ; Zhu JX; Zhu XD; Li HJ; Han LS; Gu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):31-4. PubMed ID: 18289467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem mass spectrometric analysis for disorders in amino, organic and fatty acid metabolism: two year experience in South Korea.
    Yoon HR; Lee KR; Kim H; Kang S; Ha Y; Lee DH
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():115-20. PubMed ID: 15906713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
    Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
    Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia.
    Shigematsu Y; Hata I; Tanaka Y
    Clin Chim Acta; 2007; 386(1-2):82-6. PubMed ID: 17850781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.
    Rashed MS; Ozand PT; Bucknall MP; Little D
    Pediatr Res; 1995 Sep; 38(3):324-31. PubMed ID: 7494654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan.
    Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Sakura N; Tajima T; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):39-48. PubMed ID: 12127323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.
    Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA
    Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple acyl-CoA-dehydrogenase deficiency (MADD): use of acylcarnitines and fatty acids to monitor the response to dietary treatment.
    Abdenur JE; Chamoles NA; Schenone AB; Jorge L; Guinle A; Bernard C; Levandovskiy V; Fusta M; Lavorgna S
    Pediatr Res; 2001 Jul; 50(1):61-6. PubMed ID: 11420420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Variants of inborn errors of metabolism with late onset but nevertheless life threatening course].
    Plöchl E; Plöchl W; Wermuth B; Roscher AA
    Klin Padiatr; 2001; 213(5):261-5. PubMed ID: 11582523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development, validation and application of tandem mass spectrometry for screening of inborn metabolic disorders in Kuwaiti infants.
    Abdel-Hamid M; Tisocki K; Sharaf L; Ramadan D
    Med Princ Pract; 2007; 16(3):215-21. PubMed ID: 17409757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Deficiency of the fatty-acid oxidising enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in an adult, detected during a neonatal screening programme].
    Derks TG; Jakobs H; Gerding A; Niezen-Koning KE; Reijngoud DJ; Smit GP
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2185-90. PubMed ID: 15559414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data.
    Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F
    J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.